We are seeing many changes as a result of Covid.
The Decline of the High Street accelerated and a reduction in Office Space
demand being just two consequences.
As regards Inflation, a close family member who runs a business with 6 employees
reports an almost 20% price increase in two different materials used.
Wages in China increasing, often poor quality product and shipping disruption due to
Covid, not to mention Political Risk.
This can only lead to more local manufacture as Emill11 states.
Braveheart has was incorporated in 2003.
It has held stakes in many Companies for many years including
Paraytec.
Paraytec was held by Viking Fund Managers, a subsiduary and on
4th July 2016 Braveheart further invested, eventually aquiring 100% of
Paraytec.
So don't lie with allegations of short term interest.
Chamberlin is making 101 redundancies, which were announced in March,leaving a 138-strong workforce.
Sad news for those employees losing their jobs.
However it is reducing overheads and hopefully securing the jobs of those retained.
Any announcement of new contracts and we know where this is going.
Sangijuelas1 less of your lies or lack of research.
Braveheart is not directly linked with AstraZeneca, however Paraytec is and as
Braveheart own 100% of Paraytec it amounts to the same thing.
From Paraytecs own website.
Other partners in the consortium were Malvern Panalytical, CPI, UCLan, AstraZeneca, Fujifilm Diosynth Biotechnologies and GSK,
No doubt a significant amount of Placed shares are being flipped.
However almost 30% are Trevor Browns and it is my belief he will be holding for
much higher prices.
More being sold be long term shareholders who thought they had lost the lot and
glad to exit with a fraction of their original investment.
As they have been diluted in the Placing, those exiting are probably already gone.
So unless the Placing flippers are a greater percentage that I believe I think we are
already ready to move up, as seen today.
Moorhey - These free tests will fail to pick up people in the early stages of Covid, who are also
infectious. They often give a positive, where people have recently recovered fron Covid and
are no longer infectious.
The errors will be significant enough that you might as well tell people to flip a coin, rather
than waste time with these tests.
Nah - Lucky Rabbit Foot
Carl shows a photo, indicating the Virus with the caption below
"Here is a single virus coated with a fluorescent antibody which specifically recognises the viral corona"
Another Scientist asks
What viz technique is it? STORM or something?
Surely that's too small for conventional fluorescence or confocal?
I agree it is unprofessional.
It is disingenuous for him to claim it is his private Twitter
account and nothing to do with Hemogenyx.
He is well aware of the effect of his cryptic Tweets.
Just goes to show he, like all of us, is a mixture of good and bad.
There are endless reasons Directors sell, mostly neutal or negative.
Trevor Brown, with news announced Friday can sell.
He has a lot going on with Chamberlain and may need cash in relation to
his investment in that Company.
I am happy to await the next news indicated at the end of this month.
There is theory and reality.
Eli may well have no plans to bid for Hemo at this time.
However I am sure there have been discussions as to that possibility and
that Hemo may have indicated an acceptable price. One which will change over time.
My understanding is that a predator Company only has to disclose above 3%, every percentage
above that and make a bid when they exceed 30%.
Whilst Hemo have to disclose an approach,but only when it is official.
Bluemoon73 As you know the answer is zero.
No one holding below 3%, outside Hemogenyx, is required to
declare their holding.
The theory is most likely wrong, but as likely as any other.
Mints second Conversion may have been dispersed to myriad Private Investors.
But one poster thinks it all went to one holder, who holding below 3%, has
yet to declare.
Shares from Mints second loan note Conversion on 26th March went to Eli.
They are now working a third Conversion - hence weak sp.
These shares go to Eli who shoot past 3% ( with dilution say over 5%).
SP shooting up, prior to notification they have exceeded 3% holding.
SP much higher and Eli closing on 30% when they announce offer for Hemo,
HEMO Major shareholders have already indicated where an acceptable
offer needs to be and agree acceptance.
I concur with haddy68
Reading your last post Hulver it is hard not to consider the possibility
that Eli might be that holder and that a takeover might be in the offing.
I guess that is your thinking.